Literature DB >> 10372693

Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.

J Leger1, A Velasquez, C Garel, M Hassan, P Czernichow.   

Abstract

Magnetic resonance imaging (MRI) has revealed isolated pituitary stalk (PS) thickening (PST) in certain cases of idiopathic or secondary central diabetes insipidus (DI) due to infiltrative processes. Twenty-six children with DI and PST underwent cerebral MRI at the age of 8 +/- 4 yr and were followed (n = 24) by clinical and MRI evaluation, respectively, for 5.5 +/- 3.6 and 3.0 +/- 2 yr in the absence of any treatment other than hormonal substitutive therapy. Patients were subdivided into groups according to the etiology of the DI: germinoma (n = 4), Langerhans' histiocytosis (n = 5), or idiopathic DI with PST (n = 17). Complete anterior pituitary evaluation for 24 of the 26 patients revealed those suffering from associated GH deficiency (n = 14; with germinoma, n = 1; histiocytosis, n = 3; idiopathic, n = 10) and from multiple hormone deficiencies (n = 7; with germinoma, n = 3; histiocytosis, n = 1; idiopathic, n = 3). At the first MRI evaluation, PS enlargement varied from 2.2-9.0 mm at a proximal (n = 10), distal (n = 2), or middle (n = 6) PS level or along the entire PS (n = 8). The intrasellar content, which usually reflects the anterior pituitary gland, was normal (n = 12), small (n = 8), or enlarged (n = 6). At the last evaluation, a change in MRI features was found in 16 patients; morphological and/or signal changes in the PST (n = 16, of whom 6 showed an increase in PST) and changes in anterior pituitary gland size (n = 8; increased, n = 3; decreased, n = 5) were noted. The presence of a growing suprasellar mass with progressively enlarging PS was demonstrated in the 6 patients who had shown increased PS enlargement 1.8 +/- 1.6 yr after the first MRI. For 4 of them, a diagnosis of germinoma was made 1.3 +/- 0.6 yr after PST identification by MRI performed after the onset of DI, but the other 2 patients showing a suprasellar mass were still categorized as idiopathic at the final clinical evaluation performed 7.8 and 12.3 yr, respectively, after DI onset. In 10 patients (all but 1 with Langerhans histiocytosis, showing idiopathic DI), the PS enlargement was diminished after 2.0 +/- 1.9 yr of MRI follow-up, with a complete reversal of PS enlargement for 5 of them. Suprasellar mass invasion of the PS was related to multiple hormone deficiency. Although intrasellar content enlargement was observed in most patients with germinoma, a normal or small anterior pituitary gland showed no clear relationship to either clinical histories or laboratory values. In conclusion, the natural history of idiopathic isolated central DI with PST is unpredictable. Although germinoma should always be considered during the first 3 yr of follow-up in patients showing isolated DI with PST requiring repeated investigations every 3-6 months, it remains a less frequent etiology for 15% of the cases.

Entities:  

Mesh:

Year:  1999        PMID: 10372693     DOI: 10.1210/jcem.84.6.5745

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  Clinical, hormonal and imaging findings in 27 children with central diabetes insipidus.

Authors:  Julie De Buyst; Guy Massa; Catherine Christophe; Sylvie Tenoutasse; Claudine Heinrichs
Journal:  Eur J Pediatr       Date:  2006-08-31       Impact factor: 3.183

2.  Treatment of patients with hypothalamic-pituitary lesions as adult-onset Langerhans cell histiocytosis.

Authors:  Shinsaku Imashuku; Naoko Kudo; Shigehiro Kaneda; Hiroshi Kuroda; Tsuguka Shiwa; Tetsuya Hiraiwa; Atsushi Inagaki; Akira Morimoto
Journal:  Int J Hematol       Date:  2011-10-21       Impact factor: 2.490

Review 3.  Neuroimaging of Langerhans cell histiocytosis: a radiological review.

Authors:  Vikas Chaudhary; Shahina Bano; Rainy Aggarwal; Mahender Kaur Narula; Rama Anand; Ravi Shankar Solanki; Puran Singh
Journal:  Jpn J Radiol       Date:  2013-12       Impact factor: 2.374

4.  Elevated levels of human chorionic gonadotropin-beta, a marker of active neurohypophyseal germinoma, detected by immune complex transfer enzyme immunoassay.

Authors:  Atsuko Yoshizawa; Susumu Yokoya; Kenichi Oyama; Syozo Yamada
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

5.  Lymphocytic hypophysitis with central diabetes insipidus and subsequent hypopituitarism masking a suprasellar germinoma in a 13-year-old girl.

Authors:  Yoko Mikami-Terao; Masaharu Akiyama; Takaaki Yanagisawa; Junko Takahashi-Fujigasaki; Kentaro Yokoi; Kohei Fukuoka; Mio Sakuma; Ichiro Miyata; Kohji Fujisawa; Shizuo Oi; Yoshikatsu Eto
Journal:  Childs Nerv Syst       Date:  2006-03-25       Impact factor: 1.475

Review 6.  MRI of the hypothalamic-pituitary axis in children.

Authors:  Maria I Argyropoulou; Dimitrios Nikiforos Kiortsis
Journal:  Pediatr Radiol       Date:  2005-06-01

7.  Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.

Authors:  Sayali A Ranadive; Baran Ersoy; Helene Favre; Clement C Cheung; Stephen M Rosenthal; Walter L Miller; Christian Vaisse
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-18       Impact factor: 3.478

8.  Single center study of 53 consecutive patients with pituitary stalk lesions.

Authors:  Mirjana Doknic; Dragana Miljic; Sandra Pekic; Marko Stojanovic; Dragan Savic; Emilija Manojlovic-Gacic; Tatjana Milenkovic; Vera Zdravkovic; Maja Jesic; Dusan Damjanovic; Slobodan Lavrnic; Ivan Soldatovic; Aleksandar Djukic; Milan Petakov
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

9.  Pituitary stalk thickening and primary central nervous system lymphoma.

Authors:  M Capra; D Wherrett; S Weitzman; P Dirks; C Hawkins; E Bouffet
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 10.  Lymphocytic infundibulo-neurohypophysitis: a clinical overview.

Authors:  Philip C Johnston; Luen S Chew; Amir H Hamrahian; Laurence Kennedy
Journal:  Endocrine       Date:  2015-07-29       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.